Answers are grounded in this paper and cite their sources.
Single-crystalline ZnO nanobelt-like structures (NBS) of length, width, and thickness in the ranges of 5–10 μm, 50–400 nm, and 20–100 nm, respectively, are synthesized by a one-step, template-free electrochemical deposition technique at 0 °C. Scanning electron microscopy and transmission electron microscopy (TEM) reveal a unique morphology of the as-synthesized NBS, with an oval-shaped cross section. High-resolution TEM and selected area electron diffraction studies further confirm that individual NBS are single-crystalline, with a growth direction of [101̅0], while the X-ray diffraction data indicate its characteristic wurtzite structure. The successful formation of ZnO NBS at 0 °C using this simple, aqueous-solution-based, bottom-up approach is further exploited to fabricate a bionanocomposite. In particular, incorporation of a biomolecule, i.e., glucose oxidase (GOx) into the ZnO NBS in situ during electrodeposition is found to be highly effective in enhancing the activity and stability. The resulting GOx-embedded ZnO NBS are found to exhibit not only a higher enzymatic activity but also remarkable stability when compared to GOx surface-immobilized ZnO NBS. The present direct biomolecular embedment approach promises a new strategy for incorporating other compatible biomolecules in situ at low temperature while preserving their bioactivity.
No takes yet. Share an insight, caveat, or question.
Pradhan et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: